Oncology medicines for dermatological use
Original notice title
FURNIZARE MEDICAMENTE PENTRU PROGRAMUL NAȚIONAL DE ONCOLOGIE
Opportunity Score
Why this score?
Opportunity
60 / 100
Complexity
75 / 100
Risk factors
The tender is published on 2026-06-03 with deadline 2026-07-03, leaving about one month for preparation and submission...
All submissions and supporting documents must be in Romanian, which may be a barrier for non-Romanian bidders.
Submission deadline in 9 days
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Strong opportunityKey Facts
- RON 20.7M estimated value
- Framework procurement
- Supplies contract
- 3 lots
- Duration 24 MONTH
- Supply of 35 oncology medicine lots under a 24-month framework agreement
- Products are classified under CPV 33631400 (Antibiotics and chemotherapeutics for dermatological use)
Show full summary
This tender is a 24-month framework agreement for the supply of 35 oncology medicine lots (CPV 33631400) to Spitalul Orasenesc Bolintin Vale in Giurgiu, Romania. The total estimated value is RON 20,659,080, aggregated from lot-level framework maximum values. Submission is electronic via e-licitatie.ro by 2026-07-03 12:00 UTC, in Romanian language. Award criteria vary per lot: some lots use lowest price (60% price, 40% quality), others are purely quality-based or price-based according to structured data (but XML shows a consistent 60/40 split). Bidders must complete a DUAE and provide trade register certificates upon request. No variants allowed. No EU funding. The notice only was analyzed; no procurement documents were reviewed.
Risks
The tender is published on 2026-06-03 with deadline 2026-07-03, leaving about one month for preparation and submission...
All submissions and supporting documents must be in Romanian, which may be a barrier for non-Romanian bidders.
Submission deadline in 9 days
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Administrative
- Submission deadline: 2026-07-03 12:00 UTC (15:00 Romanian time)
- Electronic submission via e-licitatie.ro is mandatory
- Language: Romanian (RON) exclusively
Award Criteria
Lot 1
Lot 2
Lot 3
Lot 4
Lot 5
Lot 6
Lot 7
Lot 8
Lot 9
Lot 10
Lot 11
Lot 12
Lot 13
Lot 14
Lot 15
Lot 16
Lot 17
Lot 18
Lot 19
Lot 20
Lot 21
Lot 22
Lot 23
Lot 24
Lot 25
Lot 26
Lot 27
Lot 28
Lot 29
Lot 30
Lot 31
Lot 32
Lot 33
Lot 34
Lot 35
Buyer
Name
SPITALUL ORASENESC BOLINTIN VALE
Location
Bolintin-Vale, ROU
Website
Buyer profile
Identifier
4352689
Lots (35)
LOT-0001
PACLITAXEL 6 mg/ml
Supply of Paclitaxel 6 mg/ml with minimum and maximum quantities specified. Estimated value RON 46,080.
RON 46.1k
Estimated value
Location
Duration
Category
Selection criteria
Deadline
Award details
Value note
Framework maximum value
Show original TED data
Original TED description
Cantitate minima AC - 36 - maxima AC - 144; Cantitate minima CS I (iulie – decemb. 2026) – 6; Cantitate maxima CS I (iulie – decemb. 2026) – 36; Cantitate minima CS II (ian. – decembr. 2027) – 15; Cantitate maxima CS II (ian. – decembr. 2027) – 72; Cantitate minima CS III (ian. – iunie 2028) – 15; Cantitate maxima CS III (ian. – iunie 2028) – 36;
LOT-0002
DOCETAXEL 80 mg/4 ml
Supply of oncology medicine (CPV 33631400). Estimated value RON 103,680.
RON 103.7k
Estimated value
Location
Duration
Category
Selection criteria
Deadline
Award details
Value note
Framework maximum value
Show original TED data
Original TED description
Cantitate minima AC - 48 - maxima AC - 192; Cantitate minima CS I (iulie – decemb. 2026) – 8; Cantitate maxima CS I (iulie – decemb. 2026) – 48; Cantitate minima CS II (ian. – decembr. 2027) – 20; Cantitate maxima CS II (ian. – decembr. 2027) – 96; Cantitate minima CS III (ian. – iunie 2028) – 20; Cantitate maxima CS III (ian. – iunie 2028) – 48;
LOT-0003
DOCETXEL 20 mg/ml
Supply of oncology medicine (CPV 33631400). Estimated value RON 38,400.
RON 38.4k
Estimated value
Location
Duration
Category
Selection criteria
Deadline
Award details
Value note
Framework maximum value
Show original TED data
Original TED description
Cantitate minima AC - 48 - maxima AC - 192; Cantitate minima CS I (iulie – decemb. 2026) – 8; Cantitate maxima CS I (iulie – decemb. 2026) – 48; Cantitate minima CS II (ian. – decembr. 2027) – 20; Cantitate maxima CS II (ian. – decembr. 2027) – 96; Cantitate minima CS III (ian. – iunie 2028) – 20; Cantitate maxima CS III (ian. – iunie 2028) – 48;
LOT-0004
CICLOFOSFAMIDA 1000 mg/2 ml
Cantitate minima AC - 36 - maxima AC - 144; Cantitate minima CS I (iulie – decemb. 2026) – 6; Cantitate maxima CS I (iulie – decemb. 2026) – 36; Cantitate minima CS II (ian. – decembr. 2027) – 15; Cantitate maxima CS II (ian. – decembr. 2027) – 72; Cantitate minima CS III (ian. – iunie 2028) – 15; Cantitate maxima CS III (ian. – iunie 2028) – 36;
RON 93.6k
Estimated value
Location
Duration
Category
Selection criteria
Award details
Framework maximum value
LOT-0005
FLUOROURACIL 50mg/ml
Cantitate minima AC - 48 - maxima AC - 192; Cantitate minima CS I (iulie – decemb. 2026) – 8; Cantitate maxima CS I (iulie – decemb. 2026) – 48; Cantitate minima CS II (ian. – decembr. 2027) – 20; Cantitate maxima CS II (ian. – decembr. 2027) – 96; Cantitate minima CS III (ian. – iunie 2028) – 20; Cantitate maxima CS III (ian. – iunie 2028) – 48;
RON 12.5k
Estimated value
Location
Duration
Category
Selection criteria
Award details
Framework maximum value
LOT-0006
GEMCITABINA 100mg/ml – conc pt sol perf
Cantitate minima AC - 60 - maxima AC - 240; Cantitate minima CS I (iulie – decemb. 2026) – 10; Cantitate maxima CS I (iulie – decemb. 2026) – 60; Cantitate minima CS II (ian. – decembr. 2027) – 25; Cantitate maxima CS II (ian. – decembr. 2027) – 120; Cantitate minima CS III (ian. – iunie 2028) – 25; Cantitate maxima CS III (ian. – iunie 2028) – 60;
RON 39.6k
Estimated value
Location
Duration
Category
Selection criteria
Award details
Framework maximum value
LOT-0007
OXILIPLATIN 5 mg/ml – conc pt sol perf
Cantitate minima AC - 120 - maxima AC - 480; Cantitate minima CS I (iulie – decemb. 2026) – 20; Cantitate maxima CS I (iulie – decemb. 2026) – 120; Cantitate minima CS II (ian. – decembr. 2027) – 50; Cantitate maxima CS II (ian. – decembr. 2027) – 240; Cantitate minima CS III (ian. – iunie 2028) – 50; Cantitate maxima CS III (ian. – iunie 2028) – 120;
RON 45.6k
Estimated value
Location
Duration
Category
Selection criteria
Award details
Framework maximum value
LOT-0008
IRINOTECAN 20 mg/ml – conc pt sol perf
Cantitate minima AC - 60 - maxima AC - 240; Cantitate minima CS I (iulie – decemb. 2026) – 10; Cantitate maxima CS I (iulie – decemb. 2026) – 60; Cantitate minima CS II (ian. – decembr. 2027) – 25; Cantitate maxima CS II (ian. – decembr. 2027) – 120; Cantitate minima CS III (ian. – iunie 2028) – 25; Cantitate maxima CS III (ian. – iunie 2028) – 60;
RON 28.8k
Estimated value
Location
Duration
Category
Selection criteria
Award details
Framework maximum value
LOT-0009
IRINOTECAN 20 mg/ml – conc pt sol perf 2 ml
Cantitate minima AC - 24 - maxima AC - 96; Cantitate minima CS I (iulie – decemb. 2026) – 4; Cantitate maxima CS I (iulie – decemb. 2026) – 24; Cantitate minima CS II (ian. – decembr. 2027) – 10; Cantitate maxima CS II (ian. – decembr. 2027) – 48; Cantitate minima CS III (ian. – iunie 2028) – 10; Cantitate maxima CS III (ian. – iunie 2028) – 24;
RON 4.8k
Estimated value
Location
Duration
Category
Selection criteria
Award details
Framework maximum value
LOT-0010
ACID ZOLEDRONIC 4 mg/100 ml
Cantitate minima AC - 60 - maxima AC - 240; Cantitate minima CS I (iulie – decemb. 2026) – 10; Cantitate maxima CS I (iulie – decemb. 2026) – 60; Cantitate minima CS II (ian. – decembr. 2027) – 25; Cantitate maxima CS II (ian. – decembr. 2027) – 120; Cantitate minima CS III (ian. – iunie 2028) – 25; Cantitate maxima CS III (ian. – iunie 2028) – 60;
RON 24k
Estimated value
Location
Duration
Category
Selection criteria
Award details
Framework maximum value
LOT-0011
BEVACIZUMAB 100 mg – conc pt sol perf
Cantitate minima AC - 60 - maxima AC - 240; Cantitate minima CS I (iulie – decemb. 2026) – 10; Cantitate maxima CS I (iulie – decemb. 2026) – 60; Cantitate minima CS II (ian. – decembr. 2027) – 25; Cantitate maxima CS II (ian. – decembr. 2027) – 120; Cantitate minima CS III (ian. – iunie 2028) – 25; Cantitate maxima CS III (ian. – iunie 2028) – 60;
RON 228k
Estimated value
Location
Duration
Category
Selection criteria
Award details
Framework maximum value
LOT-0012
BEVACIZUMAN 400 mg – conc pt sol perf
Cantitate minima AC - 60 - maxima AC - 240; Cantitate minima CS I (iulie – decemb. 2026) – 10; Cantitate maxima CS I (iulie – decemb. 2026) – 60; Cantitate minima CS II (ian. – decembr. 2027) – 25; Cantitate maxima CS II (ian. – decembr. 2027) – 120; Cantitate minima CS III (ian. – iunie 2028) – 25; Cantitate maxima CS III (ian. – iunie 2028) – 60;
RON 792k
Estimated value
Location
Duration
Category
Selection criteria
Award details
Framework maximum value
LOT-0013
PANITUMUMAB 400 mg – conc pt sol perf
Cantitate minima AC - 60 - maxima AC - 240; Cantitate minima CS I (iulie – decemb. 2026) – 10; Cantitate maxima CS I (iulie – decemb. 2026) – 60; Cantitate minima CS II (ian. – decembr. 2027) – 25; Cantitate maxima CS II (ian. – decembr. 2027) – 120; Cantitate minima CS III (ian. – iunie 2028) – 25; Cantitate maxima CS III (ian. – iunie 2028) – 60;
RON 813.6k
Estimated value
Location
Duration
Category
Selection criteria
Award details
Framework maximum value
LOT-0014
PANITUMUMAB 100 mg – conc pt sol perf
Cantitate minima AC – 24 - maxima AC - 96; Cantitate minima CS I (iulie – decemb. 2026) – 4; Cantitate maxima CS I (iulie – decemb. 2026) – 24; Cantitate minima CS II (ian. – decembr. 2027) – 10; Cantitate maxima CS II (ian. – decembr. 2027) – 48; Cantitate minima CS III (ian. – iunie 2028) – 10; Cantitate maxima CS III (ian. – iunie 2028) – 24;
RON 139.2k
Estimated value
Location
Duration
Category
Selection criteria
Award details
Framework maximum value
LOT-0015
CAELYX 2 mg/ml – conc pt sol perf
Cantitate minima AC – 24 - maxima AC - 96; Cantitate minima CS I (iulie – decemb. 2026) – 4; Cantitate maxima CS I (iulie – decemb. 2026) – 24; Cantitate minima CS II (ian. – decembr. 2027) – 10; Cantitate maxima CS II (ian. – decembr. 2027) – 48; Cantitate minima CS III (ian. – iunie 2028) – 10; Cantitate maxima CS III (ian. – iunie 2028) – 24;
RON 148.8k
Estimated value
Location
Duration
Category
Selection criteria
Award details
Framework maximum value
LOT-0016
CARBOPLATIN 450 mg – conc pt sol perf
Cantitate minima AC – 60 - maxima AC - 240; Cantitate minima CS I (iulie – decemb. 2026) – 10; Cantitate maxima CS I (iulie – decemb. 2026) – 60; Cantitate minima CS II (ian. – decembr. 2027) – 25; Cantitate maxima CS II (ian. – decembr. 2027) – 120; Cantitate minima CS III (ian. – iunie 2028) – 25; Cantitate maxima CS III (ian. – iunie 2028) – 60;
RON 48k
Estimated value
Location
Duration
Category
Selection criteria
Award details
Framework maximum value
LOT-0017
CARBOPLATIN 150 mg – conc pt sol perf
Cantitate minima AC – 60 - maxima AC - 240; Cantitate minima CS I (iulie – decemb. 2026) – 10; Cantitate maxima CS I (iulie – decemb. 2026) – 60; Cantitate minima CS II (ian. – decembr. 2027) – 25; Cantitate maxima CS II (ian. – decembr. 2027) – 120; Cantitate minima CS III (ian. – iunie 2028) – 25; Cantitate maxima CS III (ian. – iunie 2028) – 60;
RON 20.4k
Estimated value
Location
Duration
Category
Selection criteria
Award details
Framework maximum value
LOT-0018
CISPLATINA 1 mg / ml – conc pt sol perf
Cantitate minima AC – 60 - maxima AC - 240; Cantitate minima CS I (iulie – decemb. 2026) – 10; Cantitate maxima CS I (iulie – decemb. 2026) – 60; Cantitate minima CS II (ian. – decembr. 2027) – 25; Cantitate maxima CS II (ian. – decembr. 2027) – 120; Cantitate minima CS III (ian. – iunie 2028) – 25; Cantitate maxima CS III (ian. – iunie 2028) – 60;
RON 19.2k
Estimated value
Location
Duration
Category
Selection criteria
Award details
Framework maximum value
LOT-0019
EPIRUBICINA 2 mg/ml – sol inj/perf
Cantitate minima AC – 60 - maxima AC - 240; Cantitate minima CS I (iulie – decemb. 2026) – 10; Cantitate maxima CS I (iulie – decemb. 2026) – 60; Cantitate minima CS II (ian. – decembr. 2027) – 25; Cantitate maxima CS II (ian. – decembr. 2027) – 120; Cantitate minima CS III (ian. – iunie 2028) – 25; Cantitate maxima CS III (ian. – iunie 2028) – 60;
RON 52.8k
Estimated value
Location
Duration
Category
Selection criteria
Award details
Framework maximum value
LOT-0020
ETOPOSIDE 20 mg/ml – conc pt sol perf
Cantitate minima AC – 108 - maxima AC - 432; Cantitate minima CS I (iulie – decemb. 2026) – 18; Cantitate maxima CS I (iulie – decemb. 2026) – 108; Cantitate minima CS II (ian. – decembr. 2027) – 45; Cantitate maxima CS II (ian. – decembr. 2027) – 216; Cantitate minima CS III (ian. – iunie 2028) – 45; Cantitate maxima CS III (ian. – iunie 2028) – 108;
RON 73.4k
Estimated value
Location
Duration
Category
Selection criteria
Award details
Framework maximum value
LOT-0021
PEMETREXED 500 mg – pulb pt conc pt sol perf
Cantitate minima AC – 48 - maxima AC - 192; Cantitate minima CS I (iulie – decemb. 2026) – 8; Cantitate maxima CS I (iulie – decemb. 2026) – 48; Cantitate minima CS II (ian. – decembr. 2027) – 20; Cantitate maxima CS II (ian. – decembr. 2027) – 96; Cantitate minima CS III (ian. – iunie 2028) – 20; Cantitate maxima CS III (ian. – iunie 2028) – 48;
RON 576k
Estimated value
Location
Duration
Category
Selection criteria
Award details
Framework maximum value
LOT-0022
CABAZITAXEL 10 mg/ml – conc pt sol perf
Cantitate minima AC – 24 - maxima AC - 96; Cantitate minima CS I (iulie – decemb. 2026) – 4; Cantitate maxima CS I (iulie – decemb. 2026) – 24; Cantitate minima CS II (ian. – decembr. 2027) – 10; Cantitate maxima CS II (ian. – decembr. 2027) – 48; Cantitate minima CS III (ian. – iunie 2028) – 10; Cantitate maxima CS III (ian. – iunie 2028) – 24;
RON 1.4M
Estimated value
Location
Duration
Category
Selection criteria
Award details
Framework maximum value
LOT-0023
CALCIUMFOLINATE 10 mg/ml – sol inj/perf
Cantitate minima AC – 60 maxima AC - 240; Cantitate minima CS I (iulie – decemb. 2026) – 10; Cantitate maxima CS I (iulie – decemb. 2026) – 60; Cantitate minima CS II (ian. – decembr. 2027) – 25; Cantitate maxima CS II (ian. – decembr. 2027) – 120; Cantitate minima CS III (ian. – iunie 2028) – 25; Cantitate maxima CS III (ian. – iunie 2028) – 60;
RON 192k
Estimated value
Location
Duration
Category
Selection criteria
Award details
Framework maximum value
LOT-0024
TRASTUZUMAB 150 mg – pulb pt conc pt sol perf
Cantitate minima AC – 24 - maxima AC - 96; Cantitate minima CS I (iulie – decemb. 2026) – 4; Cantitate maxima CS I (iulie – decemb. 2026) – 24; Cantitate minima CS II (ian. – decembr. 2027) – 10; Cantitate maxima CS II (ian. – decembr. 2027) – 48; Cantitate minima CS III (ian. – iunie 2028) – 10; Cantitate maxima CS III (ian. – iunie 2028) – 24;
RON 163.2k
Estimated value
Location
Duration
Category
Selection criteria
Award details
Framework maximum value
LOT-0025
NAB PACLITAXEL 5 mg/ml – pulb pt suspensie perfuzabila
Cantitate minima AC – 24 - maxima AC - 96; Cantitate minima CS I (iulie – decemb. 2026) – 4; Cantitate maxima CS I (iulie – decemb. 2026) – 24; Cantitate minima CS II (ian. – decembr. 2027) – 10; Cantitate maxima CS II (ian. – decembr. 2027) – 48; Cantitate minima CS III (ian. – iunie 2028) – 10; Cantitate maxima CS III (ian. – iunie 2028) – 24;
RON 76.8k
Estimated value
Location
Duration
Category
Selection criteria
Award details
Framework maximum value
LOT-0026
PEMBROLIZUMAB 25 mg/ml – conc pt sol perf
Cantitate minima AC – 60 - maxima AC - 240; Cantitate minima CS I (iulie – decemb. 2026) – 10; Cantitate maxima CS I (iulie – decemb. 2026) – 60; Cantitate minima CS II (ian. – decembr. 2027) – 25; Cantitate maxima CS II (ian. – decembr. 2027) – 120; Cantitate minima CS III (ian. – iunie 2028) – 25; Cantitate maxima CS III (ian. – iunie 2028) – 60;
RON 3M
Estimated value
Location
Duration
Category
Selection criteria
Award details
Framework maximum value
LOT-0027
NIVOLUMAB 100 mg/ml – conc pt sol perf
Cantitate minima AC – 60 - maxima AC - 240; Cantitate minima CS I (iulie – decemb. 2026) – 10; Cantitate maxima CS I (iulie – decemb. 2026) – 60; Cantitate minima CS II (ian. – decembr. 2027) – 25; Cantitate maxima CS II (ian. – decembr. 2027) – 120; Cantitate minima CS III (ian. – iunie 2028) – 25; Cantitate maxima CS III (ian. – iunie 2028) – 60;
RON 1.2M
Estimated value
Location
Duration
Category
Selection criteria
Award details
Framework maximum value
LOT-0028
NIVOLUMAB 10 mg/ml – conc pt sol perf-
Cantitate minima AC – 30 - maxima AC - 120; Cantitate minima CS I (iulie – decemb. 2026) – 5; Cantitate maxima CS I (iulie – decemb. 2026) – 30; Cantitate minima CS II (ian. – decembr. 2027) – 15; Cantitate maxima CS II (ian. – decembr. 2027) – 60; Cantitate minima CS III (ian. – iunie 2028) – 10; Cantitate maxima CS III (ian. – iunie 2028) – 30;
RON 252k
Estimated value
Location
Duration
Category
Selection criteria
Award details
Framework maximum value
LOT-0029
DURVALUMAB 50 mg/ml – conc pt sol perf
Cantitate minima AC – 54 - maxima AC - 216; Cantitate minima CS I (iulie – decemb. 2026) – 9; Cantitate maxima CS I (iulie – decemb. 2026) – 54; Cantitate minima CS II (ian. – decembr. 2027) – 30; Cantitate maxima CS II (ian. – decembr. 2027) – 108; Cantitate minima CS III (ian. – iunie 2028) – 15; Cantitate maxima CS III (ian. – iunie 2028) – 54;
RON 496.8k
Estimated value
Location
Duration
Category
Selection criteria
Award details
Framework maximum value
LOT-0030
IPILIMUMAB 5 mg/ml – conc pt sol perf
Cantitate minima AC – 24- maxima AC - 96; Cantitate minima CS I (iulie – decemb. 2026) – 4; Cantitate maxima CS I (iulie – decemb. 2026) – 24; Cantitate minima CS II (ian. – decembr. 2027) – 10; Cantitate maxima CS II (ian. – decembr. 2027) – 48; Cantitate minima CS III (ian. – iunie 2028) – 10; Cantitate maxima CS III (ian. – iunie 2028) – 24;
RON 1.3M
Estimated value
Location
Duration
Category
Selection criteria
Award details
Framework maximum value
LOT-0031
RAMUCIRUMABUM 10 mg/ml – conc pt sol perf
Cantitate minima AC – 42- maxima AC - 168; Cantitate minima CS I (iulie – decemb. 2026) – 7; Cantitate maxima CS I (iulie – decemb. 2026) – 42; Cantitate minima CS II (ian. – decembr. 2027) – 30; Cantitate maxima CS II (ian. – decembr. 2027) – 84; Cantitate minima CS III (ian. – iunie 2028) – 35; Cantitate maxima CS III (ian. – iunie 2028) – 42;
RON 621.6k
Estimated value
Location
Duration
Category
Selection criteria
Award details
Framework maximum value
LOT-0032
ATEZOLIZUMAB 1200 mg/20 ml – conc pt sol perf
Cantitate minima AC – 60 - maxima AC - 240; Cantitate minima CS I (iulie – decemb. 2026) – 10; Cantitate maxima CS I (iulie – decemb. 2026) – 60; Cantitate minima CS II (ian. – decembr. 2027) – 25; Cantitate maxima CS II (ian. – decembr. 2027) – 120; Cantitate minima CS III (ian. – iunie 2028) – 25; Cantitate maxima CS III (ian. – iunie 2028) – 60;
RON 4.1M
Estimated value
Location
Duration
Category
Selection criteria
Award details
Framework maximum value
LOT-0033
TRABECTIDIN 1 mg – pulb pt conc pt sol perf
Cantitate minima AC – 60 - maxima AC - 240; Cantitate minima CS I (iulie – decemb. 2026) – 10; Cantitate maxima CS I (iulie – decemb. 2026) – 60; Cantitate minima CS II (ian. – decembr. 2027) – 25; Cantitate maxima CS II (ian. – decembr. 2027) – 120; Cantitate minima CS III (ian. – iunie 2028) – 25; Cantitate maxima CS III (ian. – iunie 2028) – 60;
RON 1.4M
Estimated value
Location
Duration
Category
Selection criteria
Award details
Framework maximum value
LOT-0034
AVELUMABUM 20 mg/ml – conc pt sol perf
Cantitate minima AC – 60 - maxima AC - 240; Cantitate minima CS I (iulie – decemb. 2026) – 10; Cantitate maxima CS I (iulie – decemb. 2026) – 60; Cantitate minima CS II (ian. – decembr. 2027) – 25; Cantitate maxima CS II (ian. – decembr. 2027) – 120; Cantitate minima CS III (ian. – iunie 2028) – 25; Cantitate maxima CS III (ian. – iunie 2028) – 60;
RON 792k
Estimated value
Location
Duration
Category
Selection criteria
Award details
Framework maximum value
LOT-0035
ALDURAZYME 100 U/ml – conc pt sol perf
Cantitate minima AC – 243- maxima AC - 972; Cantitate minima CS I (iulie – decemb. 2026) – 43; Cantitate maxima CS I (iulie – decemb. 2026) – 243; Cantitate minima CS II (ian. – decembr. 2027) – 100; Cantitate maxima CS II (ian. – decembr. 2027) – 486; Cantitate minima CS III (ian. – iunie 2028) – 100; Cantitate maxima CS III (ian. – iunie 2028) – 243;
RON 2.3M
Estimated value
Location
Duration
Category
Selection criteria
Award details
Framework maximum value
Procurement Details
- Publication date
- 03 Jun 2026
- Notice type
- Contract notice — standard
- Languages
- Romanian
Reference metadata
- Notice subtype
- 16
- Notice version
- 1
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 384035-2026
- Source notice ID
- a13a8a60-d18e-41a2-8a52-75fd12ec054a
Documents (2)
Similar tenders
Romania – Various medicinal products – ACORD CADRU FURNIZARE MEDICAMENTE SI SOLUTII PERFUZABILE 24 LUNI
Romania – Pharmaceutical products – Acord cadru centralizat pentru 24 luni de furnizare OTC-uri IV/2026
Romania – Pharmaceutical products – Acord cadru de furnizare Medicamente
Romania – Pharmaceutical products – FURNIZARE PRODUSE SI PREPARATE FARMACEUTICE 2026
Romania – Various medicinal products – ACHIZITIE MEDICAMENTE PENTRU PERIOADA 2026-2027 la SPITALUL MUNICIPAL TURDA
Poland – Antibacterials for systemic use – Dostawy produktów leczniczych - antybiotyki
Opportunity Score
Why this score?
Opportunity
60 / 100
Complexity
75 / 100
Risk factors
The tender is published on 2026-06-03 with deadline 2026-07-03, leaving about one month for preparation and submission...
All submissions and supporting documents must be in Romanian, which may be a barrier for non-Romanian bidders.
Submission deadline in 9 days
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications